Skip to content

The role of azithromycin in acute exacerbation of asthma in children

Azithromycin for acute exacerbation of asthma in children- A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051280
Enrollment
58
Registered
2023-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: The compare effect of azithromycin and placebo in acute exacerbation of asthma: To compare the effect of azithromycin versus placebo on length of hospital stay and number of emergency d

Sponsors

Rimpi Konchikol Momin
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between the ages of completed 5 years and completed 18 years hospitalized with acute exacerbation of asthma

Exclusion criteria

Exclusion criteria: 1. Use of antibiotics during the 30 days prior to enrolment in study and documented fever (temp >38 degree celsius) 2. contraindication for use of azithromycin 3. Significant medical co-morbidity: Congenital and acquired heart disease, chronic lung disease, tuberculosis, cholestatic jaundice 4. Life threatening exacerbation requiring PICU admissions. 5. children already enrolled in the study and presenting within 60 days of discharge from hospital.

Design outcomes

Primary

MeasureTime frame
Average Length of hospital stayTimepoint: Length of hospital stay

Secondary

MeasureTime frame
1. number of Emergency Department re-visit for troublesome asthma symptoms within next 60 days after discharge from hospital. 2.Persistence of symptoms (cough and/or subjective breathlessness) beyond 1 week after discharge from hospital. 3.Time to next exacerbation during 60 days after discharge. 4.Admission to ICU. 5.Change in Pulmonary Index Score during admission.Timepoint: 60 days

Countries

India

Contacts

Public ContactDr Rimpi Konchikol Momin

Government Medical College and Hospital

drpankaj.kr@gmail.com8894286467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026